Literature DB >> 31420426

Alport syndrome with bilateral simultaneous anterior and posterior lenticonus with severe temporal macular thinning.

Vinita Gupta1, Mahsa Jamil1, Saurabh Luthra2, Athul S Puthalath1.   

Abstract

Alport syndrome (AS) is a hereditary disease with various modes of inheritance, X-linked being the the most common. Anterior lenticonus is the characteristic abnormality along with perimacular and peripheral fleck retinopathy. Our two cases of AS had simultaneous anterior and posterior lenticonus with severe temporal macular thinning on optical coherence tomography with no specific renal symptomatology and were diagnosed as AS without any invasive renal biopsy. First patient was a 19-year-old man who presented with compound myopia due to bilateral anterior and posterior lenticonus with perimacular fleck retinopathy and lozenge sign and bilateral moderate sensorineural hearing loss (SNHL). Second patient was a 24-year-old man who presented with difficulty in vision due to bilateral anterior and posterior lenticonus with bilateral severe SNHL. Our cases emphasise the crucial role of an ophthalmologist in diagnosing AS before the onset of renal symptoms and prompting further nephrological work-up in the patient or the carrier. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  chronic renal failure; ear, nose and throat/otolaryngology; genetic screening/counselling; macula; proteinurea

Mesh:

Year:  2019        PMID: 31420426      PMCID: PMC6700549          DOI: 10.1136/bcr-2019-229554

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  2 in total

1.  Temporal retinal thinning might be an early diagnostic indicator in male pediatric X-linked Alport syndrome.

Authors:  Rui-Lin Zhu; Liang Zhao; Xiao-Peng Gu; Ya-Di Zhang; Fang Wang; Yan-Qin Zhang; Liu Yang
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

Review 2.  Ocular Manifestations and Potential Treatments of Alport Syndrome: A Systematic Review.

Authors:  Rahul Ramakrishnan; Atira Shenoy; Damon Meyer
Journal:  J Ophthalmol       Date:  2022-09-08       Impact factor: 1.974

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.